TEN-YEAR LOCOREGIONAL RECURRENCE RISKS IN WOMEN WITH NODAL MICROMETASTATIC BREAST CANCER STAGED WITH AXILLARY DISSECTION

被引:14
|
作者
Lupe, Krystine [2 ]
Truong, Pauline T. [1 ,2 ,3 ]
Alexander, Cheryl [1 ]
Speers, Caroline [1 ]
Tyldesley, Scott [1 ,2 ,3 ]
机构
[1] British Columbia Canc Agcy, Vancouver Isl Ctr, Breast Canc Outcomes Unit, Victoria, BC V8R 6V5, Canada
[2] British Columbia Canc Agcy, Vancouver Isl Ctr, Dept Radiat Oncol, Victoria, BC V8R 6V5, Canada
[3] Univ British Columbia, Victoria, BC, Canada
关键词
Breast cancer; Nodal micrometastasis; Locoregional recurrence; Radiotherapy; ISOLATED TUMOR-CELLS; POSITIVE NODES; LYMPH-NODES; METASTASES; BIOPSY; PROGNOSIS; NUMBER;
D O I
10.1016/j.ijrobp.2010.12.020
中图分类号
R73 [肿瘤学];
学科分类号
100214 ;
摘要
Purpose: To compare the locoregional recurrence (LRR) rates in patients with nodal mirometastases (pNmic) with those in patients with node-negative (pN0) and macroscopic node-positive (pNmac) breast cancer; and to evaluate the LRR rates according to locoregional treatment of pNmic disease. Methods and Materials: The subjects were 9,616 women diagnosed between 1989 and 1999 with Stage pT1-T2, pN0, pNmic, or pNmac, M0 breast cancer. All women had undergone axillary dissection. The Kaplan-Meier local recurrence, regional recurrence, and LRR rates were compared among those with pN0 (n = 7,977), pNmic (n = 490) and pNmac (n = 1,149) and according to locoregional treatment. Multivariate analysis was performed to identify the significant factors associated with LRR. Results: The median follow-up was 11 years. The 10-year Kaplan-Meier recurrence rate in the pN0, pNmic, and pNmac cohorts was 6.1%, 6.8%, and 8.7% for local recurrence; 3.1%, 6.2%, and 10.3% for regional recurrence; and 8.0%, 11.6%, and 15.2% for LRR, respectively (all p < .001). In the pNmic patients, the 10-year regional recurrence rate was 6.4% with breast-conserving surgery plus breast radiotherapy (RT), 5.4% with breast-conserving surgery plus locoregional RT, 4.6% with mastectomy alone, 11.1% with mastectomy plus chest wall RT, and 10.7% with mastectomy plus locoregional RT. In patients with pNmic disease and age <45 years, Grade 3 histologic features, lymphovascular invasion, nodal ratio >0.25, and estrogen receptor-negative disease, the 10-year LRR rates were 15-20%. On multivariate analysis of the entire cohort, pNmic was associated with greater LRR than Stage pN0 (hazard ratio [HR], 1.6; p = .002). On multivariate analysis of pNmic patients only, age <45 years was associated with significantly greater LRR (HR, 1.9; p = .03), and trends for greater LRR were observed with a nodal ratio >0.25 (HR, 2.0; p = .07) and lymphovascular invasion (HR, 1.7; p = .07). Conclusion: Women with pNmic had a greater risk of LRR than those with pN0 disease. Patients with pNmic in association with young age, Grade 3 histologic features, lymphovascular invasion, nodal ratio >0.25, and estrogen receptor-negative disease experienced 10-year LRR rates of similar to 15-20%, warranting consideration of locoregional RT. (C) 2011 Elsevier Inc.
引用
收藏
页码:E681 / E688
页数:8
相关论文
共 50 条
  • [1] LOCOREGIONAL RECURRENCE RISKS IN WOMEN WITH NODAL MICROMETASTATIC BREAST CANCER
    Upe, K. L.
    Truong, P.
    Alexander, C.
    Speers, C.
    Tyldesley, S.
    RADIOTHERAPY AND ONCOLOGY, 2010, 96 : S6 - S6
  • [2] Locoregional Recurrence Risks in Women with Nodal Micrometastatic Breast Cancer
    Lupe, K. K.
    Truong, P. T.
    Alexander, C.
    Speers, C.
    Tyldesley, S.
    INTERNATIONAL JOURNAL OF RADIATION ONCOLOGY BIOLOGY PHYSICS, 2010, 78 (03): : S96 - S96
  • [3] TEN-YEAR RECURRENCE RATES IN YOUNG WOMEN WITH BREAST CANCER BY LOCOREGIONAL TREATMENT APPROACH
    Beadle, Beth M.
    Woodward, Wendy A.
    Tucker, Susan L.
    Outlaw, Elesyia D.
    Allen, Pamela K.
    Oh, Julia L.
    Strom, Eric A.
    Perkins, George H.
    Tereffe, Welela
    Yu, Tse-Kuan
    Meric-Bernstam, Funda
    Litton, Jennifer K.
    Buchholz, Thomas A.
    INTERNATIONAL JOURNAL OF RADIATION ONCOLOGY BIOLOGY PHYSICS, 2009, 73 (03): : 734 - 744
  • [4] Locoregional lymphatic recurrence following axillary dissection for breast cancer
    Lim, S. M. L.
    Lam, F. L.
    Remulla, S. J. N.
    JOURNAL OF CLINICAL ONCOLOGY, 2011, 29 (27)
  • [5] Ipsilateral nodal recurrence after axillary dissection for breast cancer
    Walsh, Nathaniel
    Kiluk, John V.
    Sun, Weihong
    Khakpour, Nazanin
    Laronga, Christine
    Lee, Marie Catherine
    JOURNAL OF SURGICAL RESEARCH, 2012, 177 (01) : 81 - 86
  • [6] Axillary recurrence in women with a negative sentinel lymph node and no axillary dissection in breast cancer
    Palesty, JA
    Foster, JM
    Hurd, TC
    Watroba, N
    Rezaishiraz, H
    Edge, SB
    JOURNAL OF SURGICAL ONCOLOGY, 2006, 93 (02) : 129 - 132
  • [7] Ten-year outcomes of targeted axillary surgery after neoadjuvant chemotherapy in breast cancer
    Lee, Jeeyeon
    Park, Junhyun
    Kang, Byeongju
    Jung, Jin Hyang
    Keum, Heejung
    Kim, Hye Jung
    Kim, Won Hwa
    Chae, Yee Soo
    Lee, Soo Jung
    Lee, In Hee
    Park, Ji-young
    Park, Jee-Young Nora
    Park, Ho Yong
    JOURNAL OF CLINICAL ONCOLOGY, 2024, 42 (16)
  • [8] Ten-year survival in women with primary stage IV breast cancer
    Lee Guek Eng
    Shaheenah Dawood
    Victoria Sopik
    Benjamin Haaland
    Pui San Tan
    Nirmala Bhoo-Pathy
    Ellen Warner
    Javaid Iqbal
    Steven A. Narod
    Rebecca Dent
    Breast Cancer Research and Treatment, 2016, 160 : 145 - 152
  • [9] 267 Axillary Recurrence Following Negative Sentinel Lymph Node Biopsy for Symptomatic Invasive Breast Cancer: A Ten-Year Review
    Khan, S.
    Shaker, H.
    Evans, S.
    Wilson, R.
    Abbas, A.
    Nasir, N.
    Ntanos, I
    Williams, K.
    Wright, C.
    Absar, M. S.
    BRITISH JOURNAL OF SURGERY, 2022, 109 (SUPPL 6)
  • [10] Ten-year survival in women with primary stage IV breast cancer
    Eng, Lee Guek
    Dawood, Shaheenah
    Sopik, Victoria
    Haaland, Benjamin
    San Tan, Pui
    Bhoo-Pathy, Nirmala
    Warner, Ellen
    Iqbal, Javaid
    Narod, Steven A.
    Dent, Rebecca
    BREAST CANCER RESEARCH AND TREATMENT, 2016, 160 (01) : 145 - 152